MedTrace Logo

Chemically Assisted Capsulectomy-A New Clinical Approach

NCT00758667 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2014-12-10

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to make available an agent,Mesna, which can assist the surgeon during the procedure of capsulectomy.

Conditions

  • Implant Capsular Contracture

Interventions

DRUG

Mesna

B. Mesna will be used to aid in the removal of the capsule when capsulectomy is performed

Sponsors & Collaborators

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Bruce Shack, MD · Vanderbit Unviersity Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2008-08-31
Completion
2009-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00758667 on ClinicalTrials.gov